Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
November 20, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program
November 19, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek Biosciences has been named “Overall BioTech Company of the Year” in the fourth annual BioTech Breakthrough Awards program.
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
November 07, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek has introduced the world’s first Enhanced Small Particle (ESP™) Detection Sorter, which opens the door to scientific discoveries.
Cytek Biosciences Reports Third Quarter 2024 Financial Results
November 05, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...
Cytek Biosciences to Participate in Upcoming Investor Conferences
October 30, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024
October 29, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the third...
Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
September 18, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
Cytek Announces Resignation of Chief Operating Officer Chris Williams
September 12, 2024 15:20 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris...
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
August 21, 2024 17:00 ET
|
Cytek Biosciences, Inc.
Cytek announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification.
Cytek Biosciences to Participate in Upcoming Investor Conferences
August 08, 2024 16:05 ET
|
Cytek Biosciences, Inc.
FREMONT, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...